NYSE : MUC

BlackRock MuniHoldings California Quality Fund, Inc.

$10.85 USD

-$0.08 (-0.73%)

Volume
206.68K
Average Volume
297.76K
Market Capitalization
$1.02B
P/E Ratio
47.17
Dividend Yield
5.92%
Price Target
Year High
$11.16
Year Low
$10.00
Day High
Day Low
Payout Ratio
$2.81
Current Ratio
$86.69
Source Headline
ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers

NEWTOWN SQUARE, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced clearance of an investigational new drug (IND) application by the United States Food and Drug Administration (FDA) for ARR-002, a potential first-in-class MUC16/NaPi2b targeting tetravalent antibody-drug conjugate (ADC) with an initial focus in ovarian and endometrial cancers and broader therapeutic potential across solid tumors.

globenewswire.com - 2026-05-07 08:00:00

Get MUC Insider Trade Alerts

MUC Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

MUC Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade